C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/14 (2006.01) A61K 31/5377 (2006.01)
Patent
CA 2508699
(E)-2-(5-Chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2- oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide in substantially crystalline form, pharmaceutical formulations thereof, processes for preparing it, and its use inmedicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
L'invention concerne des (E)-2-(5-chlorothiène-2-yle)-N-{(3S)-1[(1S)-1-méthyle-2-morpholine-4-yle-2-oxoéthyle]-2-oxopyrrolidine-3-yle}éthène-sulfonamides sous forme sensiblement cristalline, des formulations pharmaceutiques desdits composés, des procédés de préparation correspondants et leur utilisation dans le domaine médical, notamment pour améliorer un état clinique pour lequel un inhibiteur du facteur Xa est indiqué.
Dell'orco Philip C.
Kelly Henry Anderson
Shah Gita Punjabhai
Watson Nigel Stephen
Young Robert John
Glaxo Group Limited
Gowling Lafleur Henderson Llp
LandOfFree
Crystalline derivative of 2- (5-chlorothien-2-yl)-n-... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline derivative of 2- (5-chlorothien-2-yl)-n-..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline derivative of 2- (5-chlorothien-2-yl)-n-... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1433049